Vernalis plc, the parent company of Vernalis Therapeutics, Inc. is one of the UK’s leading pharmaceutical companies, Vernalis takes promising product candidates along a commercially-focused path to market. We derive pipeline candidates both from successful collaborations with a number of global pharmaceutical businesses, our own research activities and from in-licensing.
The strategy is to:
- Build a profitable and cash generative business
- Develop and commercialise low development-risk late-stage differentiated pharmaceutical products for unmet medical needs in the US
- Partner all of our NCE drug candidates
- Leverage our structure- and fragment-based drug discovery expertise through collaborations with other companies
For more information please visit us at www.vernalis.com.